Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Dec;53(12):3715-8.
doi: 10.1128/JCM.02398-15. Epub 2015 Sep 16.

The Race Is On To Shorten the Turnaround Time for Diagnosis of Multidrug-Resistant Tuberculosis

Akos Somoskovi  1 , Max Salfinger  2
Affiliations
Comment

The Race Is On To Shorten the Turnaround Time for Diagnosis of Multidrug-Resistant Tuberculosis

Akos Somoskovi et al. J Clin Microbiol. 2015 Dec.

Abstract

To realize the most benefit from multidrug-resistant tuberculosis (MDR-TB) screening, all nucleic acid amplification test (NAAT)-positive respiratory specimens should be universally tested. Once an MDR-TB diagnosis is established, additional testing is warranted to provide details about the detected mutations. The lab-on-chip technology described by A. M. Cabibbe et al. (J Clin Microbiol 53:3876-3880, 2015, http://dx.doi.org/10.1128/JCM.01824-15) potentially provides this much needed information.

PubMed Disclaimer

Comment on

References

    1. World Health Organization. 2014. Global tuberculosis report. WHO/HTM/TB/2014.08. World Health Organization, Geneva, Switzerland.
    1. Scott C, Kirking HL, Jeffries C, Price SF, Pratt R. 2015. Tuberculosis trends—United States, 2014. MMWR Morb Mortal Wkly Rep 64:265–269. - PMC - PubMed
    1. Somoskovi A, Parsons LM, Salfinger M. 2001. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res 2:164–168. doi:10.1186/rr54. - DOI - PMC - PubMed
    1. Böttger EC. 2011. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing. Clin Microbiol Infect 17:1128–1134. doi:10.1111/j.1469-0691.2011.03551.x. - DOI - PubMed
    1. Aung KJ, Van Deun A, Declercq E, Sarker MR, Das PK, Hossain MA, Rieder HL. 2014. Successful ‘9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients. Int J Tuberc Lung Dis 18:1180–1187. doi:10.5588/ijtld.14.0100. - DOI - PubMed

MeSH terms

LinkOut - more resources